In contrast, GSTZ1 and GSTA1 generally showed low expression in tumor tissues, which suggests that these enzymes mainly exhibit tumor suppressive effects, and that the reduction in GSTZ1 and GSTA1 levels is associated with poor prognosis of KIRC, ACC, and other tumors [23,25,27]. The gene discussed is GSTA1; the disease is adrenal cortex carcinoma.